XML 38 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Summary of effect of revision on affected line items within financial statements

The following table summarizes the effect of the revisions on the affected line items within the Consolidated Balance Sheets (in thousands):

June 30, 2022

 

March 31, 2022

As reported

Adjustment

As revised

As reported

Adjustment

As revised

Assets:

Current assets:

Prepaid expenses and other current assets

$

126,467

$

1,065

$

127,532

$

123,505

$

1,463

$

124,968

Total current assets

 

556,039

1,065

 

557,104

 

1,010,996

1,463

 

1,012,459

Total assets

 

3,029,175

1,065

 

3,030,240

 

3,518,460

1,463

 

3,519,923

Liabilities and shareholders' equity:

Current liabilities:

Accrued payroll and benefits

66,642

1,150

67,792

56,705

805

57,510

Deferred revenue

144,840

4,970

149,810

167,576

4,361

171,937

Total current liabilities

 

417,527

6,120

 

423,647

 

521,206

5,166

 

526,372

Noncurrent liabilities:

Other liabilities

 

65,074

8,626

 

73,700

 

65,729

8,651

 

74,380

Total noncurrent liabilities

 

1,106,581

8,626

 

1,115,207

 

1,505,947

8,651

 

1,514,598

Total liabilities

 

1,524,108

14,746

 

1,538,854

 

2,027,153

13,817

 

2,040,970

Shareholders' equity:

Retained earnings

 

2,322,810

(12,414)

 

2,310,396

 

2,314,796

(11,146)

 

2,303,650

Accumulated other comprehensive loss

(960)

(1,267)

(2,227)

(2,209)

(1,208)

(3,417)

Total shareholders' equity

 

1,505,067

(13,681)

 

1,491,386

 

1,491,307

(12,354)

 

1,478,953

Total liabilities and shareholders' equity

 

3,029,175

1,065

 

3,030,240

 

3,518,460

1,463

 

3,519,923

The following table summarizes the effect of the revisions on the affected line items within the Consolidated Statements of Income (in thousands, except per share data):

Three Months Ended March 31, 2022

 

Nine Months Ended March 31, 2022

As reported

Adjustment

As revised

As reported

Adjustment

As revised

Revenue

$

365,623

$

(1,342)

$

364,281

$

1,025,891

$

(4,696)

$

1,021,195

Operating cost and expense:

Student services and administrative expense

 

149,890

(1,027)

 

148,863

 

432,923

456

 

433,379

Total operating cost and expense

 

332,359

(1,027)

 

331,332

 

989,956

456

 

990,412

Operating income

 

33,264

(315)

 

32,949

 

35,935

(5,152)

 

30,783

Other income (expense), net

1,045

(1,372)

(327)

2,784

(349)

2,435

Loss from continuing operations before income taxes

 

(2,276)

(1,687)

 

(3,963)

 

(71,188)

(5,501)

 

(76,689)

Benefit from income taxes

 

8,133

230

 

8,363

 

38,897

700

 

39,597

Income (loss) from continuing operations

 

5,857

(1,457)

 

4,400

 

(32,291)

(4,801)

 

(37,092)

Discontinued operations:

Income from discontinued operations before income taxes

4,071

(645)

3,426

2,180

(645)

1,535

Income from discontinued operations

343,985

(645)

343,340

341,982

(645)

341,337

Net income

 

349,842

(2,102)

 

347,740

 

309,691

(5,446)

 

304,245

Earnings (loss) per share:

 

Basic:

 

Continuing operations

$

0.12

$

(0.03)

$

0.09

$

(0.65)

$

(0.10)

$

(0.75)

Discontinued operations

$

7.03

$

(0.01)

$

7.02

$

6.91

$

(0.01)

$

6.90

Total basic earnings per share

$

7.15

$

(0.04)

$

7.11

$

6.26

$

(0.11)

$

6.15

Diluted:

 

 

 

 

 

 

Continuing operations

$

0.12

$

(0.03)

$

0.09

$

(0.65)

$

(0.10)

$

(0.75)

Discontinued operations

$

6.97

$

(0.02)

$

6.95

$

6.91

$

(0.01)

$

6.90

Total diluted earnings per share

$

7.09

$

(0.05)

$

7.04

$

6.26

$

(0.11)

$

6.15

To conform to current period presentation, the previously reported interest and dividend income and investment gain lines have been condensed to other income (expense), net.

The following table summarizes the effect of the revisions on the affected line items within the Consolidated Statements of Comprehensive Income (in thousands):

Three Months Ended March 31, 2022

 

Nine Months Ended March 31, 2022

As reported

Adjustment

As revised

As reported

Adjustment

As revised

Net income

$

349,842

$

(2,102)

$

347,740

$

309,691

$

(5,446)

$

304,245

Comprehensive income before reclassification

 

349,818

(2,102)

 

347,716

 

309,703

(5,446)

 

304,257

Reclassification adjustment for realized gain on foreign currency translation adjustments

(1,551)

645

(906)

(1,551)

645

(906)

Comprehensive income

 

348,267

(1,457)

 

346,810

 

314,847

(4,801)

 

310,046

The following table summarizes the effect of the revisions on the affected line items within the Consolidated Statements of Cash Flows (in thousands):

Nine Months Ended March 31, 2022

As reported

Adjustment

As revised

Operating activities:

Net income

$

309,691

$

(5,446)

$

304,245

Income from discontinued operations

(341,982)

645

(341,337)

Loss from continuing operations

(32,291)

(4,801)

(37,092)

Adjustments to reconcile net income to net cash provided by operating activities:

Loss on investments

807

807

Changes in assets and liabilities:

Prepaid expenses and other current assets

3,531

(1,133)

2,398

Accrued payroll and benefits

(23,221)

805

(22,416)

Deferred revenue

87,811

4,696

92,507

Net cash provided by operating activities-continuing operations

58,397

374

58,771

Net cash provided by operating activities

51,482

374

51,856

Investing activities:

Proceeds from sales of marketable securities

941

941

Purchases of marketable securities

(1,315)

(1,315)

Net cash used in investing activities-continuing operations

(1,500,303)

(374)

(1,500,677)

Net cash used in investing activities

(540,938)

(374)

(541,312)

The following table summarizes the effect of the revisions on the affected line items within the Consolidated Statements of Shareholders’ Equity (in thousands):

As reported

Adjustment

As revised

June 30, 2021

Retained earnings

$

2,005,105

$

(5,700)

$

1,999,405

Accumulated other comprehensive loss

(7,365)

(1,853)

(9,218)

Total shareholders' equity

 

1,301,070

(7,553)

 

1,293,517

December 31, 2021

Retained earnings

 

1,964,954

(9,044)

 

1,955,910

Accumulated other comprehensive loss

(634)

(1,853)

(2,487)

Total shareholders' equity

 

1,287,890

(10,897)

 

1,276,993

March 31, 2022

Retained earnings

 

2,314,796

(11,146)

 

2,303,650

Accumulated other comprehensive loss

 

(2,209)

(1,208)

 

(3,417)

Total shareholders' equity

 

1,491,307

(12,354)

 

1,478,953

June 30, 2022

Retained earnings

 

2,322,810

(12,414)

 

2,310,396

Accumulated other comprehensive loss

 

(960)

(1,267)

 

(2,227)

Total shareholders' equity

 

1,505,067

(13,681)

 

1,491,386

December 31, 2022

Retained earnings

 

2,349,146

(13,505)

 

2,335,641

Total shareholders' equity

 

1,522,722

(13,505)

 

1,509,217

Three Months Ended March 31, 2022

Net income

 

349,842

(2,102)

 

347,740

Reclassification adjustment for realized gain on foreign currency translation adjustments

(1,551)

645

(906)

Nine Months Ended March 31, 2022

Net income

 

309,691

(5,446)

 

304,245

Reclassification adjustment for realized gain on foreign currency translation adjustments

 

(1,551)

645

 

(906)